Sotera Health Company (MUN:SH5)
Germany
· Delayed Price · Currency is EUR 13.60
-0.20 (-1.45%)
At close: Mar 2, 2026
Sotera Health Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,164 | 1,100 | 1,049 | 1,004 | 931.48 | Upgrade
|
| Revenue Growth (YoY) | 5.74% | 4.88% | 4.54% | 7.75% | 13.85% | Upgrade
|
| Cost of Revenue | 518.08 | 498.15 | 472.13 | 446.68 | 412.81 | Upgrade
|
| Gross Profit | 645.53 | 602.3 | 577.16 | 557 | 518.67 | Upgrade
|
| Selling, General & Admin | 200.46 | 204.75 | 186.37 | 166.18 | 149.36 | Upgrade
|
| Amortization of Goodwill & Intangibles | 30.74 | 62.04 | 63.8 | 62.94 | 63.78 | Upgrade
|
| Operating Expenses | 231.2 | 266.79 | 250.16 | 229.12 | 213.14 | Upgrade
|
| Operating Income | 414.33 | 335.51 | 326.99 | 327.89 | 305.53 | Upgrade
|
| Interest Expense | -155.72 | -164.69 | -142.88 | -80.14 | -74.19 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.95 | -0.2 | -0.16 | -0.15 | -1.35 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.47 | 0.12 | 2.38 | -0.46 | 3.56 | Upgrade
|
| EBT Excluding Unusual Items | 260.14 | 170.74 | 186.34 | 247.14 | 233.55 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -9.61 | - | Upgrade
|
| Legal Settlements | -111.17 | -32.69 | -80.31 | -480.64 | -45.66 | Upgrade
|
| Other Unusual Items | -1.46 | -24.17 | - | - | -15.58 | Upgrade
|
| Pretax Income | 147.51 | 113.87 | 106.03 | -243.11 | 175.72 | Upgrade
|
| Income Tax Expense | 69.56 | 69.48 | 54.65 | -9.54 | 58.6 | Upgrade
|
| Earnings From Continuing Operations | 77.95 | 44.4 | 51.38 | -233.57 | 117.12 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | -0.24 | Upgrade
|
| Net Income | 77.95 | 44.4 | 51.38 | -233.57 | 116.88 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0 | 0.06 | 0.29 | - | 1.52 | Upgrade
|
| Net Income to Common | 77.95 | 44.34 | 51.09 | -233.57 | 115.36 | Upgrade
|
| Net Income Growth | 75.57% | -13.58% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 284 | 283 | 281 | 280 | 279 | Upgrade
|
| Shares Outstanding (Diluted) | 286 | 285 | 283 | 280 | 279 | Upgrade
|
| Shares Change (YoY) | 0.53% | 0.60% | 1.12% | 0.26% | 17.54% | Upgrade
|
| EPS (Basic) | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 | Upgrade
|
| EPS (Diluted) | 0.27 | 0.16 | 0.18 | -0.83 | 0.41 | Upgrade
|
| EPS Growth | 72.20% | -12.89% | - | - | - | Upgrade
|
| Free Cash Flow | 149.18 | 45.09 | -362.71 | 95.58 | 179.38 | Upgrade
|
| Free Cash Flow Per Share | 0.52 | 0.16 | -1.28 | 0.34 | 0.64 | Upgrade
|
| Gross Margin | 55.48% | 54.73% | 55.01% | 55.50% | 55.68% | Upgrade
|
| Operating Margin | 35.61% | 30.49% | 31.16% | 32.67% | 32.80% | Upgrade
|
| Profit Margin | 6.70% | 4.03% | 4.87% | -23.27% | 12.38% | Upgrade
|
| Free Cash Flow Margin | 12.82% | 4.10% | -34.57% | 9.52% | 19.26% | Upgrade
|
| EBITDA | 553.36 | 501.78 | 487.33 | 475.63 | 458.68 | Upgrade
|
| EBITDA Margin | 47.55% | 45.60% | 46.44% | 47.39% | 49.24% | Upgrade
|
| D&A For EBITDA | 139.03 | 166.28 | 160.34 | 147.75 | 153.15 | Upgrade
|
| EBIT | 414.33 | 335.51 | 326.99 | 327.89 | 305.53 | Upgrade
|
| EBIT Margin | 35.61% | 30.49% | 31.16% | 32.67% | 32.80% | Upgrade
|
| Effective Tax Rate | 47.16% | 61.01% | 51.54% | - | 33.35% | Upgrade
|
| Revenue as Reported | 1,164 | 1,100 | 1,049 | 1,004 | 931.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.